Enter inventor name

Moustafa Elsayed El-Araby

This inventor holds 28 USPTO granted patents and 1 published patent application, primarily in Cancer Treatment. Top assignees: King Abdulaziz University, The Children's Hospital of Philadelphia, Virginia Commonwealth University. Active years: 2020-2024.

USPTO Granted Patents = 28 (Patent Applications = 1)

% Patents Active = 39.3

Average Co-Inventor Count = 6.2

ph-index = 2

Forward Citations = 19(Granted Patents)

Company Filing History:

28 out of 588

King Abdulaziz University

patents

2 out of 299

The Children's Hospital of Philadelphia

patents

2 out of 419

Virginia Commonwealth University

patents

4. 1 out of 1

Illexcor Holdings, LLC

patent

where one patent can have more than one assignee

Years Active: 2020-2024

Loading Chart...

Areas of Expertise:

Benzaldehyde Compounds

Antimicrobial Compounds

Arylacetamides

5-HMF Analogs

Oxazolone Derivatives

Cytotoxic Compounds

Imidazole-Based Compounds

Antidiabetic Compounds

Pharmaceutical Compositions

Cancer Inhibitors

Chemosensitization

Propenamide Compounds

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12065408 - Benzaldehyde compounds with direct polymer destabilizing effects to treat sickle cell disease (2024-08-20),

2. 11648248 - Potent antimicrobial compounds with a pyridazine nucleus (2023-05-16),

3. 11479536 - Arylacetamides as AMP-activated protein kinase inhibitors and their use for treatment of breast cancer (2022-10-25),

4. 11458144 - Methods for using 5-HMF analogs with increased solubility to inhibit or reverse RBC sickling (2022-10-04),

5. 11345692 - 3-vinylquinolines as cancer cells inhibitors (2022-05-31),

6. 11325885 - Method for treating stomach cancer (2022-05-10),

7. 11312694 - Method for making propenamide compound (2022-04-26),

8. 11312680 - Method for treating a patient having a colon cancer (2022-04-26),

9. 11220485 - Chemotherapeutic oxazolone derivatives and pharmaceutical compositions thereof (2022-01-11),

10. 11214556 - Method of treating colorectal cancer (2022-01-04),

11. 11214537 - Method for making anti-cancer compounds (2022-01-04),

12. 11180458 - Anticancer compounds, pharmaceutical compositions thereof, and a method of treating cancer (2021-11-23),

13. 11174233 - Anti-cancer compounds having oxazolone derivation (2021-11-16),

14. 11155528 - Bis-propenamide compounds and methods of treating cancer (2021-10-26),

15. 11142493 - Pharmaceutical composition for treating cancer (2021-10-12),

Title: The Innovative Journey of Inventor Moustafa Elsayed El-Araby

Introduction: Moustafa Elsayed El-Araby is a pioneering inventor based in Jeddah, Saudi Arabia, known for his groundbreaking contributions to the field of innovations and inventions.

Latest Patents: Moustafa Elsayed El-Araby holds several patents in various technological domains, showcasing his versatility and creativity in developing novel solutions to complex problems.

Career Highlights: Throughout his illustrious career, Moustafa Elsayed El-Araby has consistently pushed the boundaries of innovation, earning recognition for his cutting-edge inventions that have had a significant impact on the industry.

Collaborations: Moustafa Elsayed El-Araby has collaborated with leading research institutions, universities, and companies worldwide, fostering a culture of innovation and knowledge sharing to drive progress in the field of inventions.

Conclusion: Moustafa Elsayed El-Araby's relentless pursuit of innovation and his passion for creating transformative solutions have solidified his reputation as a visionary inventor, inspiring the next generation of innovators to push the boundaries of what is possible.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]